FDA Supply Chain Initiative And Foreign Inspection Increases Funded Under White House ’10 Budget
This article was originally published in PharmAsia News
Executive Summary
The $3.2 billion U.S. FDA budget proposed May 7 by the Obama administration includes a number of proposals aimed at ensuring global drug safety, including a $166 million initiative for improving supply chain safety for medical products
You may also be interested in...
U.S. FDA’s International Offices To Be Fully Staffed By End Of Summer
By the end of the summer, U.S. FDA will have a permanent staff in its newly opened international offices in China, Europe, India and Latin America
U.S. FDA Says Global Drug Safety On Importers’ Shoulders
U.S. FDA is grappling with the challenges of import safety as the number of foreign-sourced drugs entering the country exceeds FDA's inspection capabilities, and the agency hopes two risk-based draft guidances will increase industry accountability and free up resources for high-risk inspections
Globalization Bill Creates Fees For Generic Pre-approval Inspections
A system for assessing fees for generic drug applicants to pay for pre-approval inspections is included in the 1FDA Globalization Act introduced in the House Jan. 28